BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30169557)

  • 1. Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management.
    Black DM; Abrahamsen B; Bouxsein ML; Einhorn T; Napoli N
    Endocr Rev; 2019 Apr; 40(2):333-368. PubMed ID: 30169557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
    Shane E; Burr D; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster DW; Ebeling PR; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Howe TS; van der Meulen MC; Weinstein RS; Whyte MP
    J Bone Miner Res; 2014 Jan; 29(1):1-23. PubMed ID: 23712442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
    Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates and the risk of atypical femur fractures.
    Black DM; Condra K; Adams AL; Eastell R
    Bone; 2022 Mar; 156():116297. PubMed ID: 34920168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
    Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS
    Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical femur fractures.
    Borrelli J; Lane J; Bukata S; Egol KA; Takemoto R; Slobogean G; Morshed S
    J Orthop Trauma; 2014; 28 Suppl 1():S36-42. PubMed ID: 24476604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
    Starr J; Tay YKD; Shane E
    Curr Osteoporos Rep; 2018 Aug; 16(4):519-529. PubMed ID: 29951870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients.
    Iizuka Y; Iizuka H; Kaneko T; Mieda T; Takechi R; Suzuki H; Sorimachi Y; Suto T; Tachibana M; Yoneyama T; Omodaka T; Hashimoto S; Hamano N; Sakane H; Shimoyama D; Kohama I; Ohshima A; Nozaki T; Kamiyama M; Moteki T; Ohshima A; Takamine S; Honda A; Ueno A; Tajika T; Okamura K; Warita T; Yonemoto Y; Shitara H; Ohsawa T; Takagishi K
    Injury; 2016 Nov; 47(11):2484-2489. PubMed ID: 27670281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.
    Shane E; Burr D; Ebeling PR; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster D; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Koval K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Sen HT; van der Meulen MC; Weinstein RS; Whyte M;
    J Bone Miner Res; 2010 Nov; 25(11):2267-94. PubMed ID: 20842676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.
    Eisenstein N; Kasavkar G; Bhavsar D; Khan FS; Paskins Z
    BMC Musculoskelet Disord; 2017 Jan; 18(1):29. PubMed ID: 28114975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
    Dell R; Greene D
    Osteoporos Int; 2018 Jun; 29(6):1277-1283. PubMed ID: 29675745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.
    van de Laarschot DM; McKenna MJ; Abrahamsen B; Langdahl B; Cohen-Solal M; Guañabens N; Eastell R; Ralston SH; Zillikens MC
    J Clin Endocrinol Metab; 2020 May; 105(5):1682-99. PubMed ID: 31867670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical fractures: An issue of concern or a myth?
    Al-Ashqar M; Panteli M; Chakrabarty G; Giannoudis PV
    Injury; 2018 Mar; 49(3):649-655. PubMed ID: 29338853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and management of atypical femur fractures.
    Divan V; Rao SD; Dhaliwal R
    Curr Opin Endocrinol Diabetes Obes; 2019 Dec; 26(6):283-290. PubMed ID: 31592780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone cross-sectional geometry is not associated with atypical femoral fractures in Asian female chronic bisphosphonate users.
    Chou AC; Ng AC; Png MA; Chua DT; Ng DC; Howe TS; Koh JS
    Bone; 2015 Oct; 79():170-5. PubMed ID: 26067179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological criteria for atypical features of femur fractures: what we can learn when applied in a clinical study setting.
    LeBlanc ES; Rosales AG; Genant HK; Dell RM; Friess DM; Boardman DL; Santora AC; Bauer DC; de Papp AE; Black DM; Orwoll ES
    Osteoporos Int; 2019 Jun; 30(6):1287-1295. PubMed ID: 30809724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment status and radiographic features of patients with atypical femoral fractures.
    Hagino H; Endo N; Yamamoto T; Harada A; Iwamoto J; Kondo N; Mashiba T; Mori S; Nakamura J; Ohtori S; Sakai A; Takada J; Kato Y
    J Orthop Sci; 2018 Mar; 23(2):316-320. PubMed ID: 29146093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication management after intramedullary nailing of atypical fractures.
    Feron JM; Cambon-Binder A
    Injury; 2017 Jun; 48 Suppl 1():S15-S17. PubMed ID: 28456365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Sato H; Kondo N; Wada Y; Nakatsue T; Iguchi S; Fujisawa J; Kazama JJ; Kuroda T; Nakano M; Endo N; Narita I
    Osteoporos Int; 2016 Mar; 27(3):1217-1225. PubMed ID: 26519417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the incidence of atypical femoral fractures and bisphosphonate therapy.
    Clout A; Narayanasamy N; Harris I
    J Orthop Surg (Hong Kong); 2016 Apr; 24(1):36-40. PubMed ID: 27122510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.